OraSure Technologies reported $360.55M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Agilent USD 13.07B 252M Mar/2026
AngioDynamics USD 269.68M 4.04M Sep/2025
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Bio Techne USD 2.55B 27.9M Mar/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Bruker USD 6.05B 77.8M Jun/2026
Cerus USD 221.86M 6.67M Dec/2025
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Danaher USD 92.37B 8.82B Jun/2026
Dentsply International USD 5.2B 25M Jun/2026
Dexcom USD 6.46B 178M Jun/2026
Illumina USD 6.65B 91M Jun/2026
Integra LifeSciences USD 3.56B 14.24M Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
IQVIA Holdings USD 29.88B 206M Jun/2026
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Mettler Toledo International USD 3.67B 2.03M Jun/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Quidel USD 5.72B 86.6M Jun/2026
Repligen USD 2.95B 19.41M Jun/2026
Revvity USD 12.05B 49.24M Jun/2026
STAAR Surgical USD 475.2M 24.09M Jun/2026
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Trinity Biotech USD 105.16M 1.45M Dec/2025
Waters USD 24.75B 220M Jun/2026